nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—CYP2E1—lung cancer	0.21	0.619	CbGaD
Dapsone—PTGS2—lung cancer	0.129	0.381	CbGaD
Dapsone—MPO—Cisplatin—lung cancer	0.0537	0.111	CbGbCtD
Dapsone—CYP3A5—Gefitinib—lung cancer	0.0216	0.0445	CbGbCtD
Dapsone—CYP3A5—Teniposide—lung cancer	0.0209	0.0431	CbGbCtD
Dapsone—PTGS2—Cisplatin—lung cancer	0.0185	0.0382	CbGbCtD
Dapsone—PTGS2—Etoposide—lung cancer	0.0182	0.0375	CbGbCtD
Dapsone—CYP2C19—Gefitinib—lung cancer	0.0174	0.0359	CbGbCtD
Dapsone—CYP2C19—Teniposide—lung cancer	0.0169	0.0348	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0156	0.0321	CbGbCtD
Dapsone—CYP3A7—Paclitaxel—lung cancer	0.0156	0.0321	CbGbCtD
Dapsone—PTGS1—Etoposide—lung cancer	0.0154	0.0317	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0154	0.0316	CbGbCtD
Dapsone—CYP3A7—Irinotecan—lung cancer	0.0154	0.0316	CbGbCtD
Dapsone—CYP2C9—Gefitinib—lung cancer	0.0145	0.0298	CbGbCtD
Dapsone—CYP2C9—Teniposide—lung cancer	0.014	0.0289	CbGbCtD
Dapsone—CYP3A5—Crizotinib—lung cancer	0.0132	0.0272	CbGbCtD
Dapsone—CYP3A5—Erlotinib—lung cancer	0.0128	0.0263	CbGbCtD
Dapsone—CYP2C8—Erlotinib—lung cancer	0.0123	0.0253	CbGbCtD
Dapsone—CYP2E1—Etoposide—lung cancer	0.0119	0.0245	CbGbCtD
Dapsone—CYP3A5—Paclitaxel—lung cancer	0.0117	0.0241	CbGbCtD
Dapsone—CYP3A5—Irinotecan—lung cancer	0.0115	0.0237	CbGbCtD
Dapsone—CYP3A7—Docetaxel—lung cancer	0.0113	0.0232	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0113	0.0232	CbGbCtD
Dapsone—CYP2C8—Paclitaxel—lung cancer	0.0112	0.0231	CbGbCtD
Dapsone—CYP3A5—Etoposide—lung cancer	0.00923	0.019	CbGbCtD
Dapsone—CYP3A4—Topotecan—lung cancer	0.0092	0.019	CbGbCtD
Dapsone—CYP2C8—Etoposide—lung cancer	0.00887	0.0183	CbGbCtD
Dapsone—CYP3A5—Docetaxel—lung cancer	0.00844	0.0174	CbGbCtD
Dapsone—CYP3A4—Gefitinib—lung cancer	0.00841	0.0173	CbGbCtD
Dapsone—CYP3A4—Teniposide—lung cancer	0.00816	0.0168	CbGbCtD
Dapsone—CYP2C9—Paclitaxel—lung cancer	0.00783	0.0161	CbGbCtD
Dapsone—CYP3A4—Vinorelbine—lung cancer	0.00648	0.0134	CbGbCtD
Dapsone—CYP2C9—Cisplatin—lung cancer	0.0063	0.013	CbGbCtD
Dapsone—CYP3A4—Crizotinib—lung cancer	0.00516	0.0106	CbGbCtD
Dapsone—CYP3A4—Erlotinib—lung cancer	0.00497	0.0102	CbGbCtD
Dapsone—CYP3A4—Paclitaxel—lung cancer	0.00455	0.00938	CbGbCtD
Dapsone—CYP3A4—Irinotecan—lung cancer	0.00449	0.00926	CbGbCtD
Dapsone—CYP3A4—Vinblastine—lung cancer	0.00399	0.00823	CbGbCtD
Dapsone—CYP3A4—Etoposide—lung cancer	0.0036	0.00741	CbGbCtD
Dapsone—CYP3A4—Docetaxel—lung cancer	0.00329	0.00678	CbGbCtD
Dapsone—CYP3A4—Doxorubicin—lung cancer	0.00245	0.00506	CbGbCtD
Dapsone—Nerve injury—Paclitaxel—lung cancer	0.00212	0.0355	CcSEcCtD
Dapsone—Hypoalbuminaemia—Paclitaxel—lung cancer	0.00212	0.0355	CcSEcCtD
Dapsone—Proteinuria—Gefitinib—lung cancer	0.00152	0.0254	CcSEcCtD
Dapsone—Protein urine present—Gefitinib—lung cancer	0.0015	0.025	CcSEcCtD
Dapsone—Skin exfoliation—Pemetrexed—lung cancer	0.00128	0.0214	CcSEcCtD
Dapsone—Swelling face—Paclitaxel—lung cancer	0.000973	0.0163	CcSEcCtD
Dapsone—Muscular weakness—Crizotinib—lung cancer	0.000939	0.0157	CcSEcCtD
Dapsone—Proteinuria—Erlotinib—lung cancer	0.000906	0.0152	CcSEcCtD
Dapsone—Protein urine present—Erlotinib—lung cancer	0.000894	0.015	CcSEcCtD
Dapsone—Pancreatitis—Pemetrexed—lung cancer	0.000825	0.0138	CcSEcCtD
Dapsone—Pancreatitis—Gefitinib—lung cancer	0.000819	0.0137	CcSEcCtD
Dapsone—Neuropathy peripheral—Crizotinib—lung cancer	0.000804	0.0135	CcSEcCtD
Dapsone—Skin exfoliation—Erlotinib—lung cancer	0.00076	0.0127	CcSEcCtD
Dapsone—Neuropathy peripheral—Pemetrexed—lung cancer	0.000735	0.0123	CcSEcCtD
Dapsone—Pharyngitis—Pemetrexed—lung cancer	0.000668	0.0112	CcSEcCtD
Dapsone—Skin exfoliation—Vinorelbine—lung cancer	0.000657	0.011	CcSEcCtD
Dapsone—Proteinuria—Gemcitabine—lung cancer	0.000629	0.0105	CcSEcCtD
Dapsone—Protein urine present—Gemcitabine—lung cancer	0.000621	0.0104	CcSEcCtD
Dapsone—Vision blurred—Crizotinib—lung cancer	0.000604	0.0101	CcSEcCtD
Dapsone—Neuropathy peripheral—Teniposide—lung cancer	0.000595	0.00997	CcSEcCtD
Dapsone—Erythema—Pemetrexed—lung cancer	0.000586	0.00981	CcSEcCtD
Dapsone—Skin exfoliation—Gemcitabine—lung cancer	0.000528	0.00884	CcSEcCtD
Dapsone—Cough—Gefitinib—lung cancer	0.000508	0.00851	CcSEcCtD
Dapsone—Skin exfoliation—Cisplatin—lung cancer	0.000492	0.00824	CcSEcCtD
Dapsone—Pancreatitis—Erlotinib—lung cancer	0.00049	0.0082	CcSEcCtD
Dapsone—FMO3—respiratory system—lung cancer	0.00046	0.094	CbGeAlD
Dapsone—Neuropathy peripheral—Vinblastine—lung cancer	0.000454	0.00761	CcSEcCtD
Dapsone—Skin exfoliation—Etoposide—lung cancer	0.000451	0.00755	CcSEcCtD
Dapsone—Skin exfoliation—Paclitaxel—lung cancer	0.000442	0.0074	CcSEcCtD
Dapsone—Neuropathy peripheral—Topotecan—lung cancer	0.000441	0.00739	CcSEcCtD
Dapsone—Muscular weakness—Vinorelbine—lung cancer	0.000441	0.00738	CcSEcCtD
Dapsone—Neuropathy peripheral—Erlotinib—lung cancer	0.000437	0.00731	CcSEcCtD
Dapsone—Pancreatitis—Vinorelbine—lung cancer	0.000423	0.00709	CcSEcCtD
Dapsone—Body temperature increased—Crizotinib—lung cancer	0.000414	0.00693	CcSEcCtD
Dapsone—Pharyngitis—Vinblastine—lung cancer	0.000413	0.00691	CcSEcCtD
Dapsone—Pharyngitis—Topotecan—lung cancer	0.000401	0.00672	CcSEcCtD
Dapsone—CYP2C18—bronchus—lung cancer	0.000394	0.0804	CbGeAlD
Dapsone—Gastrointestinal pain—Pemetrexed—lung cancer	0.000391	0.00655	CcSEcCtD
Dapsone—Gastrointestinal pain—Gefitinib—lung cancer	0.000389	0.00651	CcSEcCtD
Dapsone—FMO3—bronchus—lung cancer	0.000379	0.0773	CbGeAlD
Dapsone—Tachycardia—Teniposide—lung cancer	0.000378	0.00633	CcSEcCtD
Dapsone—Body temperature increased—Pemetrexed—lung cancer	0.000378	0.00633	CcSEcCtD
Dapsone—Abdominal pain—Pemetrexed—lung cancer	0.000378	0.00633	CcSEcCtD
Dapsone—Neuropathy peripheral—Vinorelbine—lung cancer	0.000378	0.00632	CcSEcCtD
Dapsone—Body temperature increased—Gefitinib—lung cancer	0.000376	0.00629	CcSEcCtD
Dapsone—Abdominal pain—Gefitinib—lung cancer	0.000376	0.00629	CcSEcCtD
Dapsone—Skin exfoliation—Docetaxel—lung cancer	0.000375	0.00628	CcSEcCtD
Dapsone—Sulfaphenazole—CYP2A6—lung cancer	0.00036	0.21	CrCbGaD
Dapsone—Pancreatitis—Irinotecan—lung cancer	0.000349	0.00585	CcSEcCtD
Dapsone—Erythema—Erlotinib—lung cancer	0.000348	0.00583	CcSEcCtD
Dapsone—Influenza—Gemcitabine—lung cancer	0.000347	0.00581	CcSEcCtD
Dapsone—Nasopharyngitis—Cisplatin—lung cancer	0.000335	0.0056	CcSEcCtD
Dapsone—Vomiting—Crizotinib—lung cancer	0.000333	0.00557	CcSEcCtD
Dapsone—Albuminuria—Doxorubicin—lung cancer	0.000328	0.00549	CcSEcCtD
Dapsone—Vertigo—Vinblastine—lung cancer	0.000325	0.00545	CcSEcCtD
Dapsone—Proteinuria—Methotrexate—lung cancer	0.000322	0.00539	CcSEcCtD
Dapsone—Protein urine present—Methotrexate—lung cancer	0.000318	0.00532	CcSEcCtD
Dapsone—Pancreatitis—Cisplatin—lung cancer	0.000317	0.00531	CcSEcCtD
Dapsone—Gastrointestinal pain—Teniposide—lung cancer	0.000317	0.0053	CcSEcCtD
Dapsone—Nausea—Crizotinib—lung cancer	0.000311	0.00521	CcSEcCtD
Dapsone—Cough—Topotecan—lung cancer	0.000307	0.00514	CcSEcCtD
Dapsone—Abdominal pain—Teniposide—lung cancer	0.000306	0.00513	CcSEcCtD
Dapsone—Body temperature increased—Teniposide—lung cancer	0.000306	0.00513	CcSEcCtD
Dapsone—Vomiting—Pemetrexed—lung cancer	0.000304	0.00509	CcSEcCtD
Dapsone—Cough—Erlotinib—lung cancer	0.000304	0.00509	CcSEcCtD
Dapsone—MPO—respiratory system—lung cancer	0.000304	0.0619	CbGeAlD
Dapsone—Neuropathy peripheral—Gemcitabine—lung cancer	0.000303	0.00508	CcSEcCtD
Dapsone—Vomiting—Gefitinib—lung cancer	0.000302	0.00506	CcSEcCtD
Dapsone—Erythema—Vinorelbine—lung cancer	0.000301	0.00504	CcSEcCtD
Dapsone—Nasopharyngitis—Paclitaxel—lung cancer	0.000301	0.00503	CcSEcCtD
Dapsone—Muscular weakness—Paclitaxel—lung cancer	0.000296	0.00496	CcSEcCtD
Dapsone—Influenza—Paclitaxel—lung cancer	0.000291	0.00487	CcSEcCtD
Dapsone—Pancreatitis—Paclitaxel—lung cancer	0.000285	0.00477	CcSEcCtD
Dapsone—Nausea—Pemetrexed—lung cancer	0.000284	0.00476	CcSEcCtD
Dapsone—Neuropathy peripheral—Cisplatin—lung cancer	0.000283	0.00473	CcSEcCtD
Dapsone—Nausea—Gefitinib—lung cancer	0.000282	0.00473	CcSEcCtD
Dapsone—Sulfamethazine—ALB—lung cancer	0.000279	0.163	CrCbGaD
Dapsone—Sulfadiazine—CYP2E1—lung cancer	0.000279	0.163	CrCbGaD
Dapsone—Pharyngitis—Gemcitabine—lung cancer	0.000276	0.00462	CcSEcCtD
Dapsone—Sulfamerazine—ALB—lung cancer	0.000273	0.159	CrCbGaD
Dapsone—Vertigo—Vinorelbine—lung cancer	0.00027	0.00453	CcSEcCtD
Dapsone—Skin exfoliation—Methotrexate—lung cancer	0.00027	0.00452	CcSEcCtD
Dapsone—CYP2C8—mammary gland—lung cancer	0.000266	0.0544	CbGeAlD
Dapsone—Photosensitivity reaction—Paclitaxel—lung cancer	0.000265	0.00444	CcSEcCtD
Dapsone—Cough—Vinorelbine—lung cancer	0.000263	0.0044	CcSEcCtD
Dapsone—Neuropathy peripheral—Etoposide—lung cancer	0.000259	0.00434	CcSEcCtD
Dapsone—Insomnia—Erlotinib—lung cancer	0.000257	0.0043	CcSEcCtD
Dapsone—Nasopharyngitis—Docetaxel—lung cancer	0.000255	0.00427	CcSEcCtD
Dapsone—Neuropathy peripheral—Paclitaxel—lung cancer	0.000254	0.00425	CcSEcCtD
Dapsone—MPO—epithelium—lung cancer	0.000254	0.0518	CbGeAlD
Dapsone—Vomiting—Teniposide—lung cancer	0.000246	0.00412	CcSEcCtD
Dapsone—FMO3—lung—lung cancer	0.000244	0.0499	CbGeAlD
Dapsone—Sinusitis—Paclitaxel—lung cancer	0.000243	0.00407	CcSEcCtD
Dapsone—Headache—Teniposide—lung cancer	0.000243	0.00406	CcSEcCtD
Dapsone—Erythema—Gemcitabine—lung cancer	0.000242	0.00405	CcSEcCtD
Dapsone—Gastrointestinal pain—Vinblastine—lung cancer	0.000242	0.00405	CcSEcCtD
Dapsone—Tinnitus—Cisplatin—lung cancer	0.000241	0.00404	CcSEcCtD
Dapsone—Tachycardia—Vinorelbine—lung cancer	0.00024	0.00401	CcSEcCtD
Dapsone—CYP2C9—mammary gland—lung cancer	0.000237	0.0483	CbGeAlD
Dapsone—Gastrointestinal pain—Topotecan—lung cancer	0.000235	0.00393	CcSEcCtD
Dapsone—Skin exfoliation—Doxorubicin—lung cancer	0.000234	0.00392	CcSEcCtD
Dapsone—Abdominal pain—Vinblastine—lung cancer	0.000234	0.00391	CcSEcCtD
Dapsone—Gastrointestinal pain—Erlotinib—lung cancer	0.000232	0.00389	CcSEcCtD
Dapsone—Pharyngitis—Paclitaxel—lung cancer	0.000231	0.00386	CcSEcCtD
Dapsone—Nausea—Teniposide—lung cancer	0.00023	0.00385	CcSEcCtD
Dapsone—Body temperature increased—Topotecan—lung cancer	0.000227	0.0038	CcSEcCtD
Dapsone—Abdominal pain—Topotecan—lung cancer	0.000227	0.0038	CcSEcCtD
Dapsone—Erythema—Cisplatin—lung cancer	0.000225	0.00377	CcSEcCtD
Dapsone—Body temperature increased—Erlotinib—lung cancer	0.000225	0.00376	CcSEcCtD
Dapsone—Abdominal pain—Erlotinib—lung cancer	0.000225	0.00376	CcSEcCtD
Dapsone—Vertigo—Irinotecan—lung cancer	0.000223	0.00373	CcSEcCtD
Dapsone—Tinnitus—Paclitaxel—lung cancer	0.000217	0.00363	CcSEcCtD
Dapsone—Cough—Irinotecan—lung cancer	0.000217	0.00363	CcSEcCtD
Dapsone—Neuropathy peripheral—Docetaxel—lung cancer	0.000215	0.0036	CcSEcCtD
Dapsone—Vision blurred—Cisplatin—lung cancer	0.000212	0.00356	CcSEcCtD
Dapsone—Sulfamethizole—ALB—lung cancer	0.000212	0.124	CrCbGaD
Dapsone—Cough—Gemcitabine—lung cancer	0.000211	0.00353	CcSEcCtD
Dapsone—Erythema—Paclitaxel—lung cancer	0.000202	0.00339	CcSEcCtD
Dapsone—Gastrointestinal pain—Vinorelbine—lung cancer	0.000201	0.00336	CcSEcCtD
Dapsone—Pharyngitis—Docetaxel—lung cancer	0.000196	0.00328	CcSEcCtD
Dapsone—Body temperature increased—Vinorelbine—lung cancer	0.000194	0.00325	CcSEcCtD
Dapsone—Abdominal pain—Vinorelbine—lung cancer	0.000194	0.00325	CcSEcCtD
Dapsone—Vision blurred—Paclitaxel—lung cancer	0.000191	0.00319	CcSEcCtD
Dapsone—Sulfanilamide—CYP2E1—lung cancer	0.00019	0.111	CrCbGaD
Dapsone—Vomiting—Vinblastine—lung cancer	0.000188	0.00315	CcSEcCtD
Dapsone—Vertigo—Etoposide—lung cancer	0.000185	0.00311	CcSEcCtD
Dapsone—Headache—Vinblastine—lung cancer	0.000185	0.0031	CcSEcCtD
Dapsone—Insomnia—Irinotecan—lung cancer	0.000183	0.00307	CcSEcCtD
Dapsone—Vomiting—Topotecan—lung cancer	0.000183	0.00306	CcSEcCtD
Dapsone—Vertigo—Paclitaxel—lung cancer	0.000182	0.00305	CcSEcCtD
Dapsone—Vomiting—Erlotinib—lung cancer	0.000181	0.00302	CcSEcCtD
Dapsone—Cough—Etoposide—lung cancer	0.00018	0.00302	CcSEcCtD
Dapsone—Headache—Topotecan—lung cancer	0.00018	0.00301	CcSEcCtD
Dapsone—Tachycardia—Cisplatin—lung cancer	0.00018	0.00301	CcSEcCtD
Dapsone—Insomnia—Gemcitabine—lung cancer	0.000178	0.00299	CcSEcCtD
Dapsone—Headache—Erlotinib—lung cancer	0.000178	0.00298	CcSEcCtD
Dapsone—MPO—bone marrow—lung cancer	0.000178	0.0363	CbGeAlD
Dapsone—Cough—Paclitaxel—lung cancer	0.000177	0.00296	CcSEcCtD
Dapsone—Nausea—Vinblastine—lung cancer	0.000176	0.00294	CcSEcCtD
Dapsone—Pancreatitis—Methotrexate—lung cancer	0.000174	0.00291	CcSEcCtD
Dapsone—Erythema—Docetaxel—lung cancer	0.000172	0.00287	CcSEcCtD
Dapsone—Nausea—Topotecan—lung cancer	0.000171	0.00286	CcSEcCtD
Dapsone—Nausea—Erlotinib—lung cancer	0.000169	0.00283	CcSEcCtD
Dapsone—FMO3—lymph node—lung cancer	0.000167	0.0341	CbGeAlD
Dapsone—Gastrointestinal pain—Irinotecan—lung cancer	0.000166	0.00277	CcSEcCtD
Dapsone—Tachycardia—Etoposide—lung cancer	0.000164	0.00275	CcSEcCtD
Dapsone—Photosensitivity reaction—Methotrexate—lung cancer	0.000162	0.00271	CcSEcCtD
Dapsone—Tachycardia—Paclitaxel—lung cancer	0.000161	0.0027	CcSEcCtD
Dapsone—MPO—lung—lung cancer	0.000161	0.0329	CbGeAlD
Dapsone—CYP3A5—respiratory system—lung cancer	0.00016	0.0327	CbGeAlD
Dapsone—Abdominal pain—Irinotecan—lung cancer	0.00016	0.00268	CcSEcCtD
Dapsone—Body temperature increased—Irinotecan—lung cancer	0.00016	0.00268	CcSEcCtD
Dapsone—Nasopharyngitis—Doxorubicin—lung cancer	0.000159	0.00266	CcSEcCtD
Dapsone—Muscular weakness—Doxorubicin—lung cancer	0.000157	0.00263	CcSEcCtD
Dapsone—Vomiting—Vinorelbine—lung cancer	0.000156	0.00262	CcSEcCtD
Dapsone—Body temperature increased—Gemcitabine—lung cancer	0.000156	0.00261	CcSEcCtD
Dapsone—Headache—Vinorelbine—lung cancer	0.000154	0.00258	CcSEcCtD
Dapsone—Influenza—Doxorubicin—lung cancer	0.000154	0.00257	CcSEcCtD
Dapsone—Pancreatitis—Doxorubicin—lung cancer	0.000151	0.00252	CcSEcCtD
Dapsone—Cough—Docetaxel—lung cancer	0.00015	0.00251	CcSEcCtD
Dapsone—CYP2E1—respiratory system—lung cancer	0.000149	0.0305	CbGeAlD
Dapsone—Insomnia—Paclitaxel—lung cancer	0.000149	0.0025	CcSEcCtD
Dapsone—Nausea—Vinorelbine—lung cancer	0.000146	0.00244	CcSEcCtD
Dapsone—Body temperature increased—Cisplatin—lung cancer	0.000145	0.00243	CcSEcCtD
Dapsone—PTGS1—respiratory system—lung cancer	0.000144	0.0294	CbGeAlD
Dapsone—Pharyngitis—Methotrexate—lung cancer	0.000141	0.00236	CcSEcCtD
Dapsone—Photosensitivity reaction—Doxorubicin—lung cancer	0.00014	0.00235	CcSEcCtD
Dapsone—Gastrointestinal pain—Etoposide—lung cancer	0.000138	0.00231	CcSEcCtD
Dapsone—PTGS2—respiratory system—lung cancer	0.000138	0.0281	CbGeAlD
Dapsone—Tachycardia—Docetaxel—lung cancer	0.000137	0.00229	CcSEcCtD
Dapsone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000135	0.00226	CcSEcCtD
Dapsone—Neuropathy peripheral—Doxorubicin—lung cancer	0.000134	0.00225	CcSEcCtD
Dapsone—Abdominal pain—Etoposide—lung cancer	0.000133	0.00223	CcSEcCtD
Dapsone—Body temperature increased—Etoposide—lung cancer	0.000133	0.00223	CcSEcCtD
Dapsone—Tinnitus—Methotrexate—lung cancer	0.000132	0.00222	CcSEcCtD
Dapsone—Abdominal pain—Paclitaxel—lung cancer	0.000131	0.00219	CcSEcCtD
Dapsone—Body temperature increased—Paclitaxel—lung cancer	0.000131	0.00219	CcSEcCtD
Dapsone—Vomiting—Irinotecan—lung cancer	0.000129	0.00216	CcSEcCtD
Dapsone—Sinusitis—Doxorubicin—lung cancer	0.000129	0.00215	CcSEcCtD
Dapsone—Headache—Irinotecan—lung cancer	0.000127	0.00213	CcSEcCtD
Dapsone—Insomnia—Docetaxel—lung cancer	0.000127	0.00212	CcSEcCtD
Dapsone—Vomiting—Gemcitabine—lung cancer	0.000125	0.0021	CcSEcCtD
Dapsone—Erythema—Methotrexate—lung cancer	0.000124	0.00207	CcSEcCtD
Dapsone—Headache—Gemcitabine—lung cancer	0.000124	0.00207	CcSEcCtD
Dapsone—Pharyngitis—Doxorubicin—lung cancer	0.000122	0.00204	CcSEcCtD
Dapsone—PTGS1—epithelium—lung cancer	0.00012	0.0246	CbGeAlD
Dapsone—Nausea—Irinotecan—lung cancer	0.00012	0.00201	CcSEcCtD
Dapsone—Sulfamethoxazole—ALB—lung cancer	0.000119	0.0694	CrCbGaD
Dapsone—Nausea—Gemcitabine—lung cancer	0.000117	0.00196	CcSEcCtD
Dapsone—Vomiting—Cisplatin—lung cancer	0.000117	0.00196	CcSEcCtD
Dapsone—Vision blurred—Methotrexate—lung cancer	0.000117	0.00195	CcSEcCtD
Dapsone—PTGS2—epithelium—lung cancer	0.000115	0.0235	CbGeAlD
Dapsone—Tinnitus—Doxorubicin—lung cancer	0.000115	0.00192	CcSEcCtD
Dapsone—Gastrointestinal pain—Docetaxel—lung cancer	0.000115	0.00192	CcSEcCtD
Dapsone—PTGS2—bronchus—lung cancer	0.000113	0.0231	CbGeAlD
Dapsone—Vertigo—Methotrexate—lung cancer	0.000111	0.00186	CcSEcCtD
Dapsone—Body temperature increased—Docetaxel—lung cancer	0.000111	0.00185	CcSEcCtD
Dapsone—Abdominal pain—Docetaxel—lung cancer	0.000111	0.00185	CcSEcCtD
Dapsone—MPO—lymph node—lung cancer	0.00011	0.0225	CbGeAlD
Dapsone—Nausea—Cisplatin—lung cancer	0.000109	0.00183	CcSEcCtD
Dapsone—Cough—Methotrexate—lung cancer	0.000108	0.00181	CcSEcCtD
Dapsone—Vomiting—Etoposide—lung cancer	0.000107	0.00179	CcSEcCtD
Dapsone—Erythema—Doxorubicin—lung cancer	0.000107	0.00179	CcSEcCtD
Dapsone—PTGS1—trachea—lung cancer	0.000106	0.0217	CbGeAlD
Dapsone—Headache—Etoposide—lung cancer	0.000106	0.00177	CcSEcCtD
Dapsone—Vomiting—Paclitaxel—lung cancer	0.000105	0.00176	CcSEcCtD
Dapsone—Headache—Paclitaxel—lung cancer	0.000104	0.00173	CcSEcCtD
Dapsone—PTGS2—trachea—lung cancer	0.000102	0.0208	CbGeAlD
Dapsone—Vision blurred—Doxorubicin—lung cancer	0.000101	0.00169	CcSEcCtD
Dapsone—Nausea—Etoposide—lung cancer	0.0001	0.00168	CcSEcCtD
Dapsone—PTGS1—cardiac atrium—lung cancer	0.0001	0.0204	CbGeAlD
Dapsone—Nausea—Paclitaxel—lung cancer	9.81e-05	0.00164	CcSEcCtD
Dapsone—Vertigo—Doxorubicin—lung cancer	9.62e-05	0.00161	CcSEcCtD
Dapsone—Cough—Doxorubicin—lung cancer	9.34e-05	0.00156	CcSEcCtD
Dapsone—Insomnia—Methotrexate—lung cancer	9.13e-05	0.00153	CcSEcCtD
Dapsone—Vomiting—Docetaxel—lung cancer	8.9e-05	0.00149	CcSEcCtD
Dapsone—Headache—Docetaxel—lung cancer	8.77e-05	0.00147	CcSEcCtD
Dapsone—Tachycardia—Doxorubicin—lung cancer	8.53e-05	0.00143	CcSEcCtD
Dapsone—CYP3A5—lung—lung cancer	8.51e-05	0.0174	CbGeAlD
Dapsone—Nausea—Docetaxel—lung cancer	8.32e-05	0.00139	CcSEcCtD
Dapsone—Gastrointestinal pain—Methotrexate—lung cancer	8.25e-05	0.00138	CcSEcCtD
Dapsone—PTGS2—bone marrow—lung cancer	8.07e-05	0.0165	CbGeAlD
Dapsone—Body temperature increased—Methotrexate—lung cancer	7.98e-05	0.00134	CcSEcCtD
Dapsone—Abdominal pain—Methotrexate—lung cancer	7.98e-05	0.00134	CcSEcCtD
Dapsone—CYP2E1—lung—lung cancer	7.94e-05	0.0162	CbGeAlD
Dapsone—Insomnia—Doxorubicin—lung cancer	7.9e-05	0.00132	CcSEcCtD
Dapsone—PTGS1—lung—lung cancer	7.65e-05	0.0156	CbGeAlD
Dapsone—PTGS2—lung—lung cancer	7.31e-05	0.0149	CbGeAlD
Dapsone—Gastrointestinal pain—Doxorubicin—lung cancer	7.15e-05	0.0012	CcSEcCtD
Dapsone—Abdominal pain—Doxorubicin—lung cancer	6.91e-05	0.00116	CcSEcCtD
Dapsone—Body temperature increased—Doxorubicin—lung cancer	6.91e-05	0.00116	CcSEcCtD
Dapsone—Vomiting—Methotrexate—lung cancer	6.42e-05	0.00107	CcSEcCtD
Dapsone—Headache—Methotrexate—lung cancer	6.32e-05	0.00106	CcSEcCtD
Dapsone—Nausea—Methotrexate—lung cancer	6e-05	0.001	CcSEcCtD
Dapsone—Vomiting—Doxorubicin—lung cancer	5.56e-05	0.000931	CcSEcCtD
Dapsone—Headache—Doxorubicin—lung cancer	5.48e-05	0.000917	CcSEcCtD
Dapsone—PTGS1—lymph node—lung cancer	5.23e-05	0.0107	CbGeAlD
Dapsone—Nausea—Doxorubicin—lung cancer	5.19e-05	0.000869	CcSEcCtD
Dapsone—PTGS2—lymph node—lung cancer	5e-05	0.0102	CbGeAlD
Dapsone—PTGS2—Metabolism—CAT—lung cancer	5.65e-06	5.19e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—APOA1—lung cancer	5.64e-06	5.18e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.62e-06	5.16e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—TERT—lung cancer	5.62e-06	5.16e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.61e-06	5.15e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.61e-06	5.15e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTA3—lung cancer	5.55e-06	5.1e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—RRM1—lung cancer	5.55e-06	5.1e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GSTT1—lung cancer	5.55e-06	5.1e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.55e-06	5.1e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ABCB1—lung cancer	5.5e-06	5.05e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.5e-06	5.05e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP2A6—lung cancer	5.49e-06	5.04e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GCLC—lung cancer	5.49e-06	5.04e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—APOA1—lung cancer	5.47e-06	5.02e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GSTP1—lung cancer	5.47e-06	5.02e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.47e-06	5.02e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GSTP1—lung cancer	5.46e-06	5.01e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—FGFR1—lung cancer	5.46e-06	5.01e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—TYMS—lung cancer	5.4e-06	4.96e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—HIF1A—lung cancer	5.37e-06	4.93e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GSTM1—lung cancer	5.34e-06	4.9e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CAT—lung cancer	5.32e-06	4.89e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CAT—lung cancer	5.31e-06	4.88e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.24e-06	4.81e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—B4GALT5—lung cancer	5.22e-06	4.79e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ENO1—lung cancer	5.2e-06	4.78e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—APOA1—lung cancer	5.19e-06	4.76e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.18e-06	4.76e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ABCB1—lung cancer	5.18e-06	4.75e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ABCB1—lung cancer	5.17e-06	4.74e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PIK3CG—lung cancer	5.15e-06	4.73e-05	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PTEN—lung cancer	5.13e-06	4.71e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CYP2E1—lung cancer	5.12e-06	4.7e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.12e-06	4.7e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—STK11—lung cancer	5.11e-06	4.69e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—TYMS—lung cancer	5.09e-06	4.67e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTA4—lung cancer	5.08e-06	4.66e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—TYMS—lung cancer	5.07e-06	4.66e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CYP1A1—lung cancer	5.06e-06	4.65e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—NQO1—lung cancer	5.06e-06	4.64e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GSTM1—lung cancer	5.03e-06	4.61e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ERCC2—lung cancer	5.02e-06	4.61e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GSTM1—lung cancer	5.02e-06	4.6e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PIK3CG—lung cancer	4.99e-06	4.58e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.95e-06	4.55e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTA2—lung cancer	4.95e-06	4.54e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.91e-06	4.51e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—POMC—lung cancer	4.9e-06	4.5e-05	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—EP300—lung cancer	4.89e-06	4.49e-05	CbGpPWpGaD
Dapsone—FMO3—Metabolism—AKT1—lung cancer	4.86e-06	4.46e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.8e-06	4.4e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CREBBP—lung cancer	4.78e-06	4.39e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTA1—lung cancer	4.78e-06	4.38e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CYP1A1—lung cancer	4.77e-06	4.37e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CYP1A1—lung cancer	4.76e-06	4.37e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—POMC—lung cancer	4.75e-06	4.36e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—APC—lung cancer	4.73e-06	4.35e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—KIT—lung cancer	4.73e-06	4.35e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GSTP1—lung cancer	4.73e-06	4.34e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ERCC2—lung cancer	4.73e-06	4.34e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ABCC3—lung cancer	4.72e-06	4.33e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ERCC2—lung cancer	4.72e-06	4.33e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—EGF—lung cancer	4.68e-06	4.3e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP2E1—lung cancer	4.67e-06	4.28e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—CREBBP—lung cancer	4.63e-06	4.25e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—NQO1—lung cancer	4.61e-06	4.24e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CAT—lung cancer	4.6e-06	4.22e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.57e-06	4.2e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—AKR1C1—lung cancer	4.57e-06	4.2e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—STK11—lung cancer	4.56e-06	4.19e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PIK3CD—lung cancer	4.53e-06	4.16e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.52e-06	4.15e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.48e-06	4.11e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ABCB1—lung cancer	4.48e-06	4.11e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—ALB—lung cancer	4.47e-06	4.1e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—BRAF—lung cancer	4.45e-06	4.08e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—UGT1A1—lung cancer	4.44e-06	4.08e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—IL6R—lung cancer	4.4e-06	4.04e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—TYMS—lung cancer	4.4e-06	4.03e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PIK3CD—lung cancer	4.39e-06	4.03e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—CREBBP—lung cancer	4.39e-06	4.03e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GSTM1—lung cancer	4.34e-06	3.99e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—APOA1—lung cancer	4.34e-06	3.99e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—ALB—lung cancer	4.33e-06	3.98e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.28e-06	3.93e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GNG11—lung cancer	4.28e-06	3.93e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GSTP1—lung cancer	4.22e-06	3.87e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MAP2K1—lung cancer	4.19e-06	3.85e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—PIK3CD—lung cancer	4.16e-06	3.82e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—STK11—lung cancer	4.16e-06	3.82e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.16e-06	3.82e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CYP1A1—lung cancer	4.12e-06	3.78e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CAT—lung cancer	4.11e-06	3.77e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—APOA1—lung cancer	4.09e-06	3.75e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ERCC2—lung cancer	4.09e-06	3.75e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.08e-06	3.75e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—APOA1—lung cancer	4.08e-06	3.75e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ALDOA—lung cancer	4.08e-06	3.74e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ABCB1—lung cancer	3.99e-06	3.67e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PIK3CG—lung cancer	3.96e-06	3.64e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NCOA3—lung cancer	3.96e-06	3.63e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PIK3CB—lung cancer	3.95e-06	3.62e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—TYMS—lung cancer	3.92e-06	3.6e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PTGS2—lung cancer	3.91e-06	3.59e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.9e-06	3.58e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GSTM1—lung cancer	3.88e-06	3.56e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ADCY1—lung cancer	3.85e-06	3.53e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ABCG2—lung cancer	3.85e-06	3.53e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GSTP1—lung cancer	3.85e-06	3.53e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PIK3CB—lung cancer	3.83e-06	3.51e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PTGS2—lung cancer	3.79e-06	3.48e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ENO2—lung cancer	3.77e-06	3.47e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—HPGDS—lung cancer	3.77e-06	3.47e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—POMC—lung cancer	3.77e-06	3.46e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.75e-06	3.44e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CAT—lung cancer	3.74e-06	3.44e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PIK3CG—lung cancer	3.73e-06	3.43e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MDM2—lung cancer	3.73e-06	3.42e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PIK3CG—lung cancer	3.72e-06	3.42e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.72e-06	3.42e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—RAF1—lung cancer	3.72e-06	3.41e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CYP1A1—lung cancer	3.68e-06	3.37e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CREBBP—lung cancer	3.68e-06	3.37e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—ERBB2—lung cancer	3.68e-06	3.37e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTT1—lung cancer	3.66e-06	3.36e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ERCC2—lung cancer	3.65e-06	3.35e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ABCB1—lung cancer	3.64e-06	3.34e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MTOR—lung cancer	3.63e-06	3.33e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—PIK3CB—lung cancer	3.63e-06	3.33e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—CD4—lung cancer	3.62e-06	3.32e-05	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PIK3CA—lung cancer	3.62e-06	3.32e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP2A6—lung cancer	3.62e-06	3.32e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GCLC—lung cancer	3.62e-06	3.32e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—TYMS—lung cancer	3.58e-06	3.28e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—POMC—lung cancer	3.55e-06	3.26e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—POMC—lung cancer	3.55e-06	3.25e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GSTM1—lung cancer	3.54e-06	3.25e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—APOA1—lung cancer	3.53e-06	3.24e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PIK3CD—lung cancer	3.49e-06	3.2e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CREBBP—lung cancer	3.46e-06	3.18e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CREBBP—lung cancer	3.45e-06	3.17e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ALB—lung cancer	3.44e-06	3.16e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ENO1—lung cancer	3.43e-06	3.15e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PTEN—lung cancer	3.41e-06	3.13e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.38e-06	3.11e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP1A1—lung cancer	3.35e-06	3.08e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ERCC2—lung cancer	3.32e-06	3.05e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PTEN—lung cancer	3.31e-06	3.04e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PIK3CD—lung cancer	3.28e-06	3.01e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PIK3CD—lung cancer	3.27e-06	3.01e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—EP300—lung cancer	3.25e-06	2.99e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ALB—lung cancer	3.24e-06	2.97e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ALB—lung cancer	3.23e-06	2.97e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PIK3CG—lung cancer	3.23e-06	2.96e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—APOA1—lung cancer	3.15e-06	2.9e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—EP300—lung cancer	3.15e-06	2.9e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—CDKN1A—lung cancer	3.14e-06	2.88e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—PTEN—lung cancer	3.13e-06	2.88e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP2E1—lung cancer	3.08e-06	2.82e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—POMC—lung cancer	3.07e-06	2.82e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NQO1—lung cancer	3.04e-06	2.79e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PIK3CB—lung cancer	3.04e-06	2.79e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.02e-06	2.77e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CREBBP—lung cancer	2.99e-06	2.75e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—EP300—lung cancer	2.99e-06	2.74e-05	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—AKT1—lung cancer	2.96e-06	2.71e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—SRC—lung cancer	2.91e-06	2.67e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PIK3CG—lung cancer	2.88e-06	2.64e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—APOA1—lung cancer	2.88e-06	2.64e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PIK3CB—lung cancer	2.86e-06	2.63e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PIK3CB—lung cancer	2.85e-06	2.62e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PIK3CD—lung cancer	2.84e-06	2.6e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PTGS2—lung cancer	2.83e-06	2.6e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PTGS2—lung cancer	2.83e-06	2.6e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—STAT3—lung cancer	2.8e-06	2.57e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ALB—lung cancer	2.8e-06	2.57e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—NRAS—lung cancer	2.8e-06	2.57e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.75e-06	2.53e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—STK11—lung cancer	2.74e-06	2.52e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—POMC—lung cancer	2.74e-06	2.52e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MAPK3—lung cancer	2.68e-06	2.46e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CREBBP—lung cancer	2.67e-06	2.45e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PIK3CG—lung cancer	2.63e-06	2.41e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PTEN—lung cancer	2.63e-06	2.41e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MYC—lung cancer	2.61e-06	2.39e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—EGFR—lung cancer	2.55e-06	2.34e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTP1—lung cancer	2.54e-06	2.33e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PIK3CD—lung cancer	2.53e-06	2.32e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—EP300—lung cancer	2.5e-06	2.3e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—POMC—lung cancer	2.5e-06	2.29e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ALB—lung cancer	2.5e-06	2.29e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PIK3CB—lung cancer	2.47e-06	2.27e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PTEN—lung cancer	2.47e-06	2.27e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CAT—lung cancer	2.47e-06	2.27e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PTEN—lung cancer	2.47e-06	2.26e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PTGS2—lung cancer	2.45e-06	2.25e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CREBBP—lung cancer	2.43e-06	2.23e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—KRAS—lung cancer	2.41e-06	2.21e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PIK3CA—lung cancer	2.41e-06	2.21e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ABCB1—lung cancer	2.4e-06	2.21e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—TYMS—lung cancer	2.36e-06	2.17e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—EP300—lung cancer	2.36e-06	2.16e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—EP300—lung cancer	2.35e-06	2.16e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PIK3CA—lung cancer	2.33e-06	2.14e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTM1—lung cancer	2.33e-06	2.14e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PIK3CD—lung cancer	2.31e-06	2.12e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ALB—lung cancer	2.28e-06	2.09e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—PIK3CA—lung cancer	2.21e-06	2.03e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP1A1—lung cancer	2.21e-06	2.03e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PIK3CB—lung cancer	2.21e-06	2.03e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ERCC2—lung cancer	2.19e-06	2.01e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PTGS2—lung cancer	2.19e-06	2.01e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PTEN—lung cancer	2.14e-06	1.96e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—HRAS—lung cancer	2.05e-06	1.88e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—EP300—lung cancer	2.04e-06	1.87e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PIK3CB—lung cancer	2.01e-06	1.85e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PTGS2—lung cancer	1.99e-06	1.83e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—AKT1—lung cancer	1.97e-06	1.8e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—IL6—lung cancer	1.96e-06	1.8e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PTEN—lung cancer	1.91e-06	1.75e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—AKT1—lung cancer	1.91e-06	1.75e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—APOA1—lung cancer	1.9e-06	1.74e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PIK3CA—lung cancer	1.85e-06	1.7e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—EP300—lung cancer	1.82e-06	1.67e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—AKT1—lung cancer	1.81e-06	1.66e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PIK3CA—lung cancer	1.74e-06	1.6e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PIK3CA—lung cancer	1.74e-06	1.6e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PTEN—lung cancer	1.74e-06	1.6e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PIK3CG—lung cancer	1.73e-06	1.59e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—EP300—lung cancer	1.66e-06	1.52e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—POMC—lung cancer	1.65e-06	1.51e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CREBBP—lung cancer	1.61e-06	1.47e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PIK3CD—lung cancer	1.52e-06	1.4e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—AKT1—lung cancer	1.51e-06	1.39e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PIK3CA—lung cancer	1.51e-06	1.38e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ALB—lung cancer	1.5e-06	1.38e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—AKT1—lung cancer	1.42e-06	1.31e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—AKT1—lung cancer	1.42e-06	1.3e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PIK3CA—lung cancer	1.35e-06	1.23e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PIK3CB—lung cancer	1.33e-06	1.22e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PTGS2—lung cancer	1.31e-06	1.21e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—AKT1—lung cancer	1.23e-06	1.13e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PIK3CA—lung cancer	1.23e-06	1.13e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PTEN—lung cancer	1.15e-06	1.05e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—AKT1—lung cancer	1.1e-06	1.01e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—EP300—lung cancer	1.09e-06	1e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—AKT1—lung cancer	1e-06	9.2e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PIK3CA—lung cancer	8.09e-07	7.42e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—AKT1—lung cancer	6.61e-07	6.07e-06	CbGpPWpGaD
